Study design.

<p>AE: adverse events.</p

Incremental costs per treatment episode—AEs of any severity.

<p>AE: adverse events; 95% confidence intervals are presented in parentheses.</p

Prevalence and characteristics of matched treatment episodes by AE.

<p>Prevalence and characteristics of matched treatment episodes by AE.</p

Incremental costs per treatment episode—severe AEs.

<p>AE: adverse events; 95% confidence intervals are presented in parentheses.</p

Patient characteristics across treatment episodes.

<p>Patient characteristics across treatment episodes.</p

Patient selection.

<p>NCCN: National Comprehensive Cancer Network, HSCT: Hematopoietic Stem Cell Transplantation, DRG: Diagnosis-Related Group.</p

Increment costs of AEs, by cancer type.

<p>AE: adverse events.</p